• to decreased the chance of severe cardiovascular (coronary heart and blood vessel) challenges in adults with kind two diabetes and heart problemsIn Oct 2024, Novo Nordisk published a examine on scientific journal Character about a novel glucose-delicate insulin NNC2215 which can cut down the potential risk of hypoglycemia in animal types.[sixty